Aldo-keto reductases: Role in cancer development and theranostics
Oncology Research · 2024 · 32 (8) · 1287-1308
DOI: 10.32604/or.2024.049918 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2024. Verfasst von Siddavaram Nagini und 3 weiteren Autor:innen. Beteiligte Einrichtung: World Neem Organization, Mumbai, 400101, India. Hauptthemen laut MEDLINE: Neoplasms, Aldo-Keto Reductases, Antineoplastic Agents. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- World Neem Organization, Mumbai, 400101, India.
- Department of Biochemistry, ICMR-National Institute of Nutrition, Hyderabad, 500007, India.
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, 10032, USA.
Zitieren
APA
Nagini, S., Kallamadi, P. R., Tanagala, K. K. K., & Reddy, G. B. (2024). Aldo-keto reductases: Role in cancer development and theranostics. Oncology Research, 32(8), 1287-1308. https://doi.org/10.32604/or.2024.049918
Vancouver
Nagini S, Kallamadi PR, Tanagala KKK, Reddy GB. Aldo-keto reductases: Role in cancer development and theranostics. Oncology Research. 2024;32(8):1287-1308. doi:10.32604/or.2024.049918
BibTeX
@article{Nagini2024,
author = {Nagini, Siddavaram and Kallamadi, Prathap Reddy and Tanagala, Kranthi Kiran Kishore and Reddy, Geereddy Bhanuprakash},
title = {Aldo-keto reductases: Role in cancer development and theranostics},
journal = {Oncology Research},
year = {2024},
volume = {32},
number = {8},
pages = {1287--1308},
doi = {10.32604/or.2024.049918}
}
EUVIMED